Here are four key notes on the technology:
1. BoneAlbumin is a serum albumin enhanced bone substitute made of fully human materials of donated bone and blood.
2. The patented albumin coating technology went through clinical trials to show positive affects.
3. The product is classified as a “human tissue product” which means there could be distribution throughout regional tissue banks.
4. OrthoSera is headquartered in Krems/Austria and has subsidiaries in the United States and Hungary. The company was formerly known as Lacerta.
More articles on orthopedic devices:
Xtant Medical receives FDA clearance for expanded product indications
Bioventus acquires BioStructures
St. Jude Medical launches Proclaim Elite SCS System in Europe
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
